SFRP2 and colorectal carcinoma: The diagnostic performance for CRC increased as the number of methylation sites increased, and the combination of SDC2‐6, SFRP2‐1, and SDC2‐1 in Model 3 showed the best diagnostic performance (AUC = 0.975) (Table S4, Supporting Information).